Albert Ferro studied Medicine at King’s College London (1978-1984), obtaining a 1st Class Honours intercalated BSc degree in Biochemistry in 1981 along the way. After qualifying, and following training as a junior doctor in medicine, he did his PhD in Clinical Pharmacology at Cambridge University. Since that time, his research and clinical interest have both focussed on the prevention and treatment of heart disease.
He has been a Consultant Physician at Guy's and St Thomas' Hospitals in London since 1996, and was appointed Professor of Cardiovascular Clinical Pharmacology at King’s College London in 2009.
Professor Ferro is ex-Vice-President (2005-2007) of the British Pharmacological Society (Clinical Section). He is Associate Medical Director of Written Examinations for MRCP(UK), having previously chaired the MRCP Part 1 Board (2015-2020) and the Royal College of Physicians Joint Specialty Committee on Clinical Pharmacology & Therapeutics (2011-2016). He served as Chair of the London Cardiovascular Society between 2005 and 2009, of which he remains a committee member.
He is a fellow of a number of professional societies including the European Society of Cardiology, British Pharmacological Society and British & Irish Hypertension Society. He is on the Editorial Boards of several medical and cardiovascular scientific journals, and is Editor in Chief of JRSM Cardiovascular Disease. He runs a hypertension clinic at Guy’s and St Thomas’.
The main focus of his present research is on the role of platelet-monocyte interactions and of inflammation in the pathophysiology of atherosclerosis, and novel therapeutic targets for atherosclerosis targeting these processes. He also has a longstanding research interest in mechanisms of regulation of vascular endothelial nitric oxide synthesis. He has published over 150 papers in peer-reviewed journals. More details about his research output and grant funding can be viewed here.